Silexion Therapeutics Corp. (SLXN)

0.3606 -0.01 (-1.90%) USD  |  NASDAQ  |  Aug 25, 13:33
More

Silexion Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SLXN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2025. Start Trial.
Date Value
December 31, 2025 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
BioLineRx Ltd. Upgrade
XTL Biopharmaceuticals Ltd. Upgrade
Kamada Ltd. Upgrade
Can-Fite BioPharma Ltd. Upgrade
Galmed Pharmaceuticals Ltd. Upgrade